Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure?

American Journal of Medicine

Volumn 101, Issue 1, 1996, Pages 49-53

  Chertow, Glenn M ^a   Sayegh, Mohamed H ^a   Allgren, Robin L ^b   Lazarus, J Michael ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Scios Nova Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANARITIDE; AURICULIN; DOPAMINE; PLACEBO; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIALYSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0030198968     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00075-7     Document Type: Article

References (15)

1. 1. Goldberg LI. Cardiovascular and renal implications of dopamine: potential clinical applications. Pharmacol Rev. 1972;24:1-29.
2. 2. Kapusta DR, Robie NW. Plasma dopamine in regulation of canine renal blood flow. Am J Physiol. 1988;255:R379-R387.
3. 3. Carey RM, Siragy HM, Ragsdale NV, et al. Dopamine-1 and dopamine-2 mechanisms in the control of renal function. Am J Hypertens. 1990;3:59S-63S.
4. 4. Hollenberg NK, Adams DF, Mendall P, et al. Renal vascular responses to dopamine: haemodynamic and angiographic observations in normal man. Clin Sci. 1973;45:733-742.
5. 5. Lee MR. Dopamine and the kidney: ten years on. Clin Sci. 1993;84:357-375.
6. 6. ter Wee P, Smit AJ, Rosman JB, et al. Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease. Am J Nephrol. 1986;6:42-46.
7. 7. McDonald R, Goldberg L, McNay J, Tuttle E. Effects of dopamine in man: augmentation of sodium excretion, glomerular filtration rate and renal plasma flow. J Clin Invest. 1964;43:1116-1124.
8. 8. Thompson BT, Cockrill BA. Renal-dose dopamine: a siren song? Lancet. 1994;344:7-8.
9. 9. Vincent JL. Renal effects of dopamine: can our dream ever come true? Crit Care Med. 1994;22:5-6.
10. 10. Szerlip HM. Renal-dose dopamine: fact and fiction. Ann Intern Med. 1991;115:153-154.
11. 11. Marbury TC, Rahman SN, Sweet RM, et al. A randomized, double-blind, placebo-controlled multi-center clinical trial of anaritide atrial natriuretic peptide in the treatment of ATN. Am Soc Nephrol. 1995;6:470. Abstract.
12. 12. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516-524.
13. 13. Cox DR. Regression models and life tables. J Royal Stat Soc. 1972;74:187-220.
14. 14. Lumlertgul D, Keoplung M, Sitprija V, et al. Furosemide and dopamine in malarial acute renal failure. Nephron. 1989;52:40-44.
15. 15. Segal J, Phang T, Walley K. Low-dose dopamine hastens the onset of gut ischemia in a porcine model of hemmorhagic shock. J Appl Physiol. 1992;73:1159-1164.